Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 14, 2025 · Filed Nov 17, 2025
The boss of TransDigm paid $800K out of pocket for TransDigm shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$800,478
Shares × reported transaction price
$500K–$1M
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
2 days after results of Nov 12, 2025, 81 days before results of Feb 3, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,340.60 on Nov 14, 2025, 9% above its 52-week low and 17% below its high, after a 4% rise over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 28% of the way up, from 250 adjusted closes. 30 trading days earlier: $1,288.83 on Oct 3, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.1% | +2.3% | −2.1% |
| 30 days | −6.5% | +2.5% | −9.0% |
| 90 days | −3.6% | +3.5% | −7.1% |
| 180 days | −12.5% | +11.9% | −24.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
TransDigm's Co-Chief Operating Officer sold $103K of TransDigm shares. Nobody planned it ahead of time.
TransDigm's Co-Chief Operating Officer sold $359K of TransDigm shares. Nobody planned it ahead of time.